...
首页> 外文期刊>Hepatitis Monthly >PREVALENCE AND RISK FACTORS FOR OBESITY AFTER LIVER TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE
【24h】

PREVALENCE AND RISK FACTORS FOR OBESITY AFTER LIVER TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE

机译:肝移植后肥胖的患病率和风险因素:单中心经验

获取原文
           

摘要

Background: The study of weight gain after transplantation and its associated factors is necessary to propose strategies to prevent and treat this problem.Objectives: This study aims to investigate factors affecting the development of obesity after liver transplantation (LTx).Patients and Methods: Medical records of 343 liver transplantation cases, which were followed between January 2001 and January 2010 at Dokuz Eylul University, were retrospectively analyzed. Patient pre-liver transplantation height, body weight, body mass index (BMI) measurements, as well as changes in body weight at the beginning, 6 months, 12 months, and 5 years post-transplantation were observed. BMI measurements with records of immunosuppressive therapies were obtained.Results: The study was carried out with the records of 226 patients. 151 patients (66.8%) were male, 75 (33.2%) were female. The mean age was 46.19±10.2 years. 123 of these liver transplants were performed from living donors, while 103 were from cadaveric donors. The causes of liver transplantation were hepatitis D virus (HDV) infection (28%), hepatitis B virus (HBV) infection (24%), hepatitis C virus (HCV) infection (24%), alcoholic liver disease (9%), cryptogenic liver disease (9%), autoimmune hepatitis (4%), and other (2%). In this study, the prevalence of obesity was 21% at the end of the second year, decreasing to 14% by the end of the fifth year. The mean BMI gradually increased during the follow-ups, reaching 25.1 kg/m2 and 26 kg/m2 six months after liver transplantation and at the end of the first year, respectively (P Conclusions: Obesity prevalence before and after liver transplantation was comparable. Education of obese patients prior to surgery and recommendation of medical nutrition therapy should be appropriate. Similar medical care for the non-obese subjects could prevent increase in obesity prevalence. Non-corticosteroid immunosuppressive agents had no significant effect on the development of weight gain and obesity. Avoiding the use of long-term steroid therapy and obesity education are the key measures for preventing obesity after liver transplantation.
机译:背景:移植后体重增加及其相关因素的研究对于提出预防和治疗该问题的策略是必要的。目的:本研究旨在研究影响肝移植后肥胖症(LTx)发展的因素。回顾性分析了2001年1月至2010年1月在Dokuz Eylul大学进行的343例肝移植病例的记录。观察患者肝移植前的身高,体重,体重指数(BMI)的测量值,以及移植后开始,6个月,12个月和5年时的体重变化。结果:本研究以226例患者的记录进行。男性151例(66.8%),女性75例(33.2%)。平均年龄为46.19±10.2岁。这些肝移植物中有123例是从活体供体中进行的,而103例是从尸体供体中进行的。肝移植的原因包括D型肝炎病毒(HDV)感染(28%),B型肝炎病毒(HBV)感染(24%),C型肝炎病毒(HCV)感染(24%),酒精性肝病(9%),隐源性肝病(9%),自身免疫性肝炎(4%)和其他(2%)。在这项研究中,肥胖的患病率在第二年末为21%,到第五年末降至14%。在随访期间,平均BMI逐渐增加,在肝移植后六个月和第一年年底分别达到25.1 kg / m 2 和26 kg / m 2 (P结论:肝移植前后的肥胖发生率具有可比性。术前对肥胖患者的教育和适当的医学营养治疗建议是适当的。对非肥胖患者进行类似的医疗护理可以防止肥胖发生率的增加。 -糖皮质激素免疫抑制剂对体重增加和肥胖的发展没有显着影响,避免长期使用类固醇疗法和肥胖教育是预防肝移植后肥胖的关键措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号